Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

acquired hemophilia

Known as: acquired haemophilia 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
We previously showed that pharmacokinetic‐guided prophylaxis (PKP) allows the dosing interval to be extended while maintaining a… Expand
Highly Cited
2013
Highly Cited
2013
It is essential to improve therapies for controlling excessive bleeding in patients with haemorrhagic disorders. As activated… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2005
Highly Cited
2005
Acquired hemophilia (AH) is an extremely rare condition in which autoantibodies (inhibitors) against clotting factor VIII induce… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
Highly Cited
2005
Highly Cited
2005
The safety and efficacy of a full-length sucrose-formulated recombinant factor VIII product (rFVIII-FS; Kogenate FS; Kogenate… Expand
2004
2004
We report on the data collected in the Italian Registry of acquired haemophilia (AH) in 2001. Recombinant activated factor VII… Expand
2003
2003
Abstract: Multicentric Castleman's Disease (MCD) is an atypical lymphoproliferative disorder, related to human herpesvirus 8 (HHV… Expand
Highly Cited
1998
Highly Cited
1998
Summary. Radiological and orthopaedic outcome in severe and moderate haemophilia A and B patients undergoing long‐term… Expand
1996
1996
In a study to demonstrate the safety and pharmacokinetics (half-life and recovery) of two different method M purified AHF… Expand
1995
1995
Summary. A 2‐year‐old girl is described with severe haemophilia A (factor VIII: C <0‐01 units/ml). Both of her parents were… Expand
Highly Cited
1991
Highly Cited
1991
In an attempt to replace the existing, DNA-based, 50% effective, carrier and prenatal diagnoses of haemophilia A with the 100… Expand